InterMed Discovery Acquires Sustainable Source for Omega-3 Fatty Acid
News Aug 21, 2009
InterMed Discovery (IMD) has announced the acquisition of microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland. This microbial source has the potential to produce Omega-3 more sustainably and reliably compared to established sources.
The two fatty acids EPA and DHA are particularly important and the concentrations of both and their ratios are directly related to the utility of Omega-3 in different therapeutic settings. At present, Omega-3 fatty acids, particularly those with high levels of EPA, are derived from fish. However, with dwindling fish populations and rising demand for Omega-3 the search for more sustainable alternatives has been on.
In addition, fish is an unreliable source since the Omega-3 concentration can exhibit significant batch variation. This is also a problem with potential alternative sources such as algae, which generate mainly DHA while the yields for EPA are very low or even none at all.
The microbial strains that IMD has acquired are sustainable sources that generate reliably high yields of Omega-3 fatty acids, which significantly out-perform current sources. This source also offers a more favorable ratio between the fatty acids DHA and EPA. This is in turn expected to lead to the development of enhanced Omega-3 formulations allowing for outstanding and new product applications for the Pharma, Food and Dietary Supplement industries.
“These microbial strains offer not only a new sustainable and reliable source of Omega-3, but also give us the capability to develop products with outstanding quality at competitive pricing,“ said Bernard Becker, Managing Director of InterMed Discovery. “This new microbial source, in conjunction with our world-class technology platform, gives us the leading edge in this competitive market and further enhances the reputation of our functional ingredients business.”
IMD will lead the collaborative research and development project with the team at the University of Saarland. Financial terms were not disclosed.
Largest Genetic Study of Osteoarthritis Advances ResearchNews
Osteoarthritis is a complex disease, and the genetic basis of the disease has proved difficult to pin down. A new study from the Sanger Institute provides much-needed hope.READ MORE
The DNA Shuffle: Barcoding Trick is Boost to RNA-SeqNews
SPLiT-seq is a new technology that can separate thousands of cells using innovative barcoding technology.READ MORE
Comments | 0 ADD COMMENT
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018